[1] M. Miyagami and Y. Kagawa, “Effectiveness of Kampo medicine Gorei-San for chronic subdural hematoma,” No Shinkei Geka, Vol. 37, No. 8, 2009, pp. 765-770. (Japanese, with English abstract)
[2] M. Muramatsu, T. Yoshikawa and K. Hanabusa, “Effectiveness of kampo medicine gorei-san-ryo for chronic subdural hematoma in very elderly patients,” No Shinkei Geka, Vol. 33, No. 10, 2005, pp. 965-969. (Japanese, with English abstract)
[3] T. F. Sun, R. Boet and W. S.Poon, “Non-surgical primary treatment of chronic subdural haematoma: Preliminary results of using dexamethasone,” B. J Neurosurg, Vol.19, No. 4, 2005, pp. 327-333.
[4] J. L. Voelker, “Nonoperative treatment of chronic subdural hematoma,” Neurosurg Clin. N Am, Vol. 11, No. 3, 2000, pp. 507-513.
[5] S. Zarkou, M. I. Aguilar, N. P. Patel, K. E. Wellik, D. M. Wingerchuk and B. M. Demaerschalk, “The role of corticosteroids in the management of chronic subdural hematomas: a critically appraised topic,” Neurologist, Vol. 15, No. 5, 2009, pp. 299-302.
[6] I. Iwai, T. Suda, F. Tozawa, Y. Nakano, Y. Sato, N. Ohmori, T. Sumitomo, M. Yamada and H. Demura, “Stimulatory effect of Saireito on proopiomelanocortin gene expression in the rat anterior pituitary gland,” Neurosci Lett. 157, Vol. 157, No. 1, 1993, pp. 37-40.
[7] Y. Nakano, T. Suda, F. Tozawa, I. Dobashi, Y. Sato, N. Ohmori, T. Sumitomo and H. Demura, “ Saireito (a Chinese herbal drug)-stimulated secretion and synthesis of pituitary ACTH are mediated by hypothalamic corticotropin-releasing factor, “ Neurosci Lett, Vol. 160, No. 1, 1993, pp. 93-95.
[8] K. S. Lee, “Natural history of chronic subdural haematoma,” Brain Inj, Vol. 18, No. 4, 2004, pp. 351-358.
[9] T. H. Tsai, A. S. Lieu, S. L. Hwang, T. Y. Huang and Y. F. Hwang, “A comparative study of the patients with bilateral or unilateral chronic subdural hematoma: precipitating factors and postoperative outcomes,” J Trauma. Vol. 68, No. 3, 2010, pp. 571-575.
[10] H. J. Hong, Y. J. Kim, H. J. Yi, Y. Ko, S. J. Oh and J. M. Kim, “Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma,” Surg Neurol, Vol. 71, NO. 2, 2009, pp. 161-166.
[11] H. Fujisawa, S. Nomura, E. Tsuchida and H. Ito, “Serum protein exudation in chronic subdural haematomas: a mechanism for haematoma enlargement?” Acta Neurochir (Wien), Vol. 140, No. 2, 1998, pp. 161-166.
[12] C. K. Park, K. H. Choi, M. C. Kim, J. K. Kang and C. R. Choi, “Spontaneous evolution of posttraumatic subdural hygroma into chronic subdural haematoma,” Acta Neurochir (Wien), Vol. 127, No.1-2, 1994, pp. 41-47.
[13] S. H. Park, S. H. Lee, J. Park, J. H. Hwang, S. K. Hwang and I. S. Hamm, “Chronic subdural hematoma preceded by traumatic subdural hygroma,” J Clin Neurosci, Vol 15, No. 8, 2008, pp. 868-872.
[14] T. Ono, N. Liu, T. Makino, F. Nogaki, E. Muso, G. Honda and T. Kita, “Suppressive mechanisms of Sairei-to on mesangial matrix expansion in rat mesangioproliferative glomerulonephritis,” Nephron Exp Nephrol, Vol. 100, No. 3, 2005, pp.e132-142.